Association of Fc gamma receptor IIA polymorphisms with acute renal-allograft rejection

Transplantation
Fang F YuanJeremy R Chapman

Abstract

Acute rejection is a leading cause of early renal-allograft failure. The human Fc gamma receptor IIA (FcgammaRIIA) forms an essential link between the humoral branch and the effector cells of the immune system. In this study, we examined FcgammaRIIA genotypes in renal-allograft recipients (rejectors) with acute graft rejection and in a number of control groups to investigate a possible association between FcgammaRIIA polymorphism and acute renal-allograft rejection. The distribution of the genotypes in the study patient group differed from the control groups. The frequency of homozygosity for FcagammaRIIA-R/R131 in the rejectors was significantly higher than that in the recipients (nonrejectors) with well-functioning renal allografts and in blood donors (P< 0.05). In comparison with the control groups, the rejectors displayed a higher R131 allele frequency (P< 0.05) and a lower H131 allele frequency (P< 0.05). These results reveal a significant association between FcgammaRIIA-R/R131 and acute renal-graft rejection, and it is likely that FcgammaRIIA polymorphisms could be useful markers for potential risk of rejection.

References

Mar 13, 2001·Annual Review of Immunology·J V Ravetch, S Bolland
Dec 26, 2001·Journal of the American Society of Nephrology : JASN·Majid ShahbaziPaul N Harden
Feb 22, 2002·Journal of the American Society of Nephrology : JASN·Shamila MauiyyediRobert B Colvin
Jul 4, 2002·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Joannis E VamvakopoulosSu M Metcalf
Nov 5, 2002·Current Opinion in Immunology·P Mark Hogarth
Dec 21, 2002·Transplantation Proceedings·A PawlikB Gawronska-Szklarz
May 20, 2003·Immunology and Cell Biology·Fang Fang YuanJohn S Sullivan
Jun 5, 2003·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Philip F Halloran
Jul 11, 2003·The New England Journal of Medicine·Minnie SarwalOscar Salvatierra

❮ Previous
Next ❯

Citations

Sep 22, 2005·Nature Reviews. Immunology·Robert B Colvin, R Neal Smith
Nov 28, 2007·Annual Review of Pathology·Lynn D CornellRobert B Colvin
Feb 12, 2014·Journal of Nephrology·Paul J PhelanMatthew A Sparks
Jan 29, 2010·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Alexander S Goldfarb-Rumyantzev, Natalie Naiman
Feb 13, 2016·Frontiers in Immunology·Michelle J HickeyElaine F Reed
Jun 23, 2007·Transplant Immunology·Gaosi XuJianghua Chen
Jun 11, 2005·Immunology·Oivind TorkildsenKjell-Morten Myhr
Jul 17, 2009·Clinical and Experimental Immunology·S BournazosI Dransfield
Oct 25, 2007·International Journal of Urology : Official Journal of the Japanese Urological Association·Shigeru SatohTomonori Habuchi
Oct 1, 2011·Transplant International : Official Journal of the European Society for Organ Transplantation·William S OettingUNKNOWN DeKAF Investigators
Feb 5, 2015·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·N M ValenzuelaE F Reed
May 29, 2015·Transplantation·Thomas ReschKatja Kotsch
Mar 25, 2015·Trends in Molecular Medicine·Kimberly A ThomasElaine F Reed
May 31, 2016·Human Immunology·Marianne DelvilleDany Anglicheau
Feb 27, 2018·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·M L ArnoldG A Böhmig
Aug 21, 2007·Clinical Journal of the American Society of Nephrology : CJASN·Kathryn J Tinckam, Anil Chandraker
Feb 26, 2019·Transplantation·William S OettingUNKNOWN DeKAF Genomics and GEN03 Investigators
Dec 3, 2016·Current Transplantation Reports·Tomas Castro-Dopico, Menna R Clatworthy
Oct 17, 2017·Transplant International : Official Journal of the European Society for Organ Transplantation·Casey R DorrAjay K Israni
Sep 10, 2021·Frontiers in Immunology·Markus WahrmannCaner Süsal

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.